Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials

A prospective path for allogeneic cellular immunotherapies.

Opinion | An Olympic-Sized Miss in Managing COVID-19

Adams was the 20th Surgeon General of the U.S. Noah Lyles’ stunning comeback to win the men’s 100-meter dash and subsequent crowning as the “world’s

August 23, 2024

Undervalued pharmaceutical stock Cybin emerges as market pioneer – Biotech Investments

EQS Newswire / 31/10/2023 / 21:41 EST/EDT Undervalued pharmaceutical stock Cybin emerges as market pioneer The stock market, being a zero-sum game, often presents

November 2, 2023

Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors | Psychedelic Invest

Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.